Agilent Technologies, Inc. (A)
NYSE: A · Real-Time Price · USD
122.90
-3.44 (-2.72%)
At close: Feb 20, 2026, 4:00 PM EST
123.74
+0.84 (0.68%)
After-hours: Feb 20, 2026, 7:06 PM EST
Agilent Technologies Revenue
In the fiscal year ending October 31, 2025, Agilent Technologies had annual revenue of $6.95B with 6.73% growth. Agilent Technologies had revenue of $1.86B in the quarter ending October 31, 2025, with 9.41% growth.
Revenue (ttm)
$6.95B
Revenue Growth
+6.73%
P/S Ratio
5.00
Revenue / Employee
$383,867
Employees
18,100
Market Cap
34.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 31, 2025 | 6.95B | 438.00M | 6.73% |
| Oct 31, 2024 | 6.51B | -323.00M | -4.73% |
| Oct 31, 2023 | 6.83B | -15.00M | -0.22% |
| Oct 31, 2022 | 6.85B | 529.00M | 8.37% |
| Oct 31, 2021 | 6.32B | 980.00M | 18.36% |
| Oct 31, 2020 | 5.34B | 176.00M | 3.41% |
| Oct 31, 2019 | 5.16B | 249.00M | 5.07% |
| Oct 31, 2018 | 4.91B | 442.00M | 9.88% |
| Oct 31, 2017 | 4.47B | 270.00M | 6.43% |
| Oct 31, 2016 | 4.20B | 164.00M | 4.06% |
| Oct 31, 2015 | 4.04B | -10.00M | -0.25% |
| Oct 31, 2014 | 4.05B | 154.00M | 3.95% |
| Oct 31, 2013 | 3.89B | -2.96B | -43.22% |
| Oct 31, 2012 | 6.86B | 243.00M | 3.67% |
| Oct 31, 2011 | 6.62B | 1.17B | 21.51% |
| Oct 31, 2010 | 5.44B | 963.00M | 21.49% |
| Oct 31, 2009 | 4.48B | -1.29B | -22.39% |
| Oct 31, 2008 | 5.77B | 354.00M | 6.53% |
| Oct 31, 2007 | 5.42B | 447.00M | 8.99% |
| Oct 31, 2006 | 4.97B | 288.00M | 6.15% |
| Oct 31, 2005 | 4.69B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IQVIA Holdings | 16.31B |
| Labcorp Holdings | 13.95B |
| Quest Diagnostics | 11.04B |
| Illumina | 4.34B |
| IDEXX Laboratories | 4.30B |
| Mettler-Toledo International | 4.03B |
| Exact Sciences | 3.25B |
| Waters | 3.17B |
A News
- 9 days ago - Bloomberg's 2026 Watch List Flags 5 Ideal 'Safer' February Dividend Buys - Seeking Alpha
- 9 days ago - Agilent Announces Cash Dividend of 25.5 Cents per Share - Business Wire
- 9 days ago - Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award - Business Wire
- 9 days ago - Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC) - Business Wire
- 14 days ago - Active Managers Add 25% to Short-Term Bond Returns - ETF Trends
- 16 days ago - Agilent Showcases Next‑Generation Automated Solutions at SLAS2026 - Business Wire
- 18 days ago - Agilent to Announce First-Quarter Fiscal Year 2026 Financial Results on Feb. 25 - Business Wire
- 24 days ago - GreensKeeper Value Fund Q4 2025 Portfolio Update: Long-Term Winners - Seeking Alpha